Electronic Journal of General Medicine

• Aire S, Garcia DP, Kajita LJ, Rati AM. Estudo hemodinamico e cineangiografico. Sociedade de Cardiologia do Estado de Sao Paulo. Cardiologia: atuoalizaçao e reciclagem. Rio de Janeiro: Atheneu; 1994. p. 159-71.
• Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Eng J Med 1996; 334:759-62.
• Still RA, McDowell IF. ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease. J Clin Pathol 1998; 51:183-8
• Faria-Neto JR, Chagas ACP, Bydlowski SP, et al. Hyperhomocystinemia in patients with coronary artery disease. Braz J Med Biol Res 2006;39(4 ):455-63.
• Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354 (9176): 407-13.
• McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56:111-28.
• Bolander-Gouaille C. Focus on Homocysteine and the Vitamins Involved in Its Metabolism. 2nd ed. Paris, France: Springer-Verlag; 2002,pp: 15.
• Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocystein as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057.
• Russo C, Girelli D, Oliveri O, Guarini P, Manzato F, Pizzola F, et al. G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 2001;103:2436-40.
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
• Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant ( 20210 G to A ) increases the risk of myocardial infarction in young women. Blood 1997;90:1747-50.

Vancouver

Demir K, Altunbaş G. Acute Myocardial Infarction in a Young Woman With Heterozygous Polymorphism for Methylenetetrahydrofolate Reductase and Prothrombin Gene Mutation. EUR J GEN MED. 2013;10(Supplement 1):66-8. https://doi.org/10.29333/ejgm/82312

APA

Demir, K., & Altunbaş, G. (2013). Acute Myocardial Infarction in a Young Woman With Heterozygous Polymorphism for Methylenetetrahydrofolate Reductase and Prothrombin Gene Mutation. European Journal of General Medicine, 10(Supplement 1), 66-68. https://doi.org/10.29333/ejgm/82312

AMA

Demir K, Altunbaş G. Acute Myocardial Infarction in a Young Woman With Heterozygous Polymorphism for Methylenetetrahydrofolate Reductase and Prothrombin Gene Mutation. EUR J GEN MED. 2013;10(Supplement 1), 66-68. https://doi.org/10.29333/ejgm/82312

Chicago

Demir, Kenan, and Gökhan Altunbaş. "Acute Myocardial Infarction in a Young Woman With Heterozygous Polymorphism for Methylenetetrahydrofolate Reductase and Prothrombin Gene Mutation". European Journal of General Medicine 2013 10 no. Supplement 1 (2013): 66-68. https://doi.org/10.29333/ejgm/82312

Harvard

Demir, K., and Altunbaş, G. (2013). Acute Myocardial Infarction in a Young Woman With Heterozygous Polymorphism for Methylenetetrahydrofolate Reductase and Prothrombin Gene Mutation. European Journal of General Medicine, 10(Supplement 1), pp. 66-68. https://doi.org/10.29333/ejgm/82312

MLA

Demir, Kenan et al. "Acute Myocardial Infarction in a Young Woman With Heterozygous Polymorphism for Methylenetetrahydrofolate Reductase and Prothrombin Gene Mutation". European Journal of General Medicine, vol. 10, no. Supplement 1, 2013, pp. 66-68. https://doi.org/10.29333/ejgm/82312